These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23605355)

  • 1. From Racemates to Single Enantiomers - Chiral Synthetic Drugs over the last 20 Years.
    Murakami H
    Top Curr Chem; 2007; 269():273-99. PubMed ID: 23605355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chiral switch: pure enantiomers of drugs instead of racemic mixtures].
    Valentová J; Hutt AJ
    Ceska Slov Farm; 2004 Nov; 53(6):285-93. PubMed ID: 15630994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putting chirality to work: the strategy of chiral switches.
    Agranat I; Caner H; Caldwell J
    Nat Rev Drug Discov; 2002 Oct; 1(10):753-68. PubMed ID: 12360254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do single enantiomers have something special to offer?
    Caldwell J
    Hum Psychopharmacol; 2001 Dec; 16(S2):S67-S71. PubMed ID: 12404710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential properties of enantiomers of commercially available racemates.
    Gulati V
    J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of thin-layer chromatography in enantiomeric chiral analysis-an overview.
    Aboul-Enein HY; El-Awady MI; Heard CM; Nicholls PJ
    Biomed Chromatogr; 1999 Dec; 13(8):531-7. PubMed ID: 10611607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective cross-sectional study to determine chirality status of registered medicines in Tanzania.
    Mwamwitwa KW; Kaibere RM; Fimbo AM; Sabitii W; Ntinginya NE; Mmbaga BT; Shewiyo DH; Shearer MC; Smith AD; Kaale EA
    Sci Rep; 2020 Oct; 10(1):17834. PubMed ID: 33082444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chirality and its implications in transdermal drug development.
    Reddy IK; Kommuru TR; Zaghloul AA; Khan MA
    Crit Rev Ther Drug Carrier Syst; 2000; 17(4):285-325. PubMed ID: 10958245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral Switch: Between Therapeutical Benefit and Marketing Strategy.
    Hancu G; Modroiu A
    Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One hundred years of helicene chemistry. Part 2: stereoselective syntheses and chiral separations of carbohelicenes.
    Gingras M; Félix G; Peresutti R
    Chem Soc Rev; 2013 Feb; 42(3):1007-50. PubMed ID: 23151610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures formed by the chiral assembly of racemic mixtures of enantiomers: iodination products of elaidic and oleic acids.
    Cai Y; Bernasek SL
    J Phys Chem B; 2005 Mar; 109(10):4514-9. PubMed ID: 16851527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chirality of Central Nervous System (CNS) Acting Drugs: A Formidable Therapeutic Hurdle Against CNS Diseases.
    Saganuwan SA
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):171-179. PubMed ID: 31232237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric processes in the large-scale preparation of chiral drug candidates.
    O'Brien MK; Vanasse B
    Curr Opin Drug Discov Devel; 2000 Nov; 3(6):793-806. PubMed ID: 19649907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient syntheses and resolutions of inherently chiral calix[4]quinolines in the cone and partial-cone conformation.
    Miao R; Zheng QY; Chen CF; Huang ZT
    J Org Chem; 2005 Sep; 70(19):7662-71. PubMed ID: 16149797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologically active compounds in the environment and their chirality.
    Kasprzyk-Hordern B
    Chem Soc Rev; 2010 Nov; 39(11):4466-503. PubMed ID: 20852776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantiomers: implications and complications in developmental pharmacology.
    Eichelbaum M
    Dev Pharmacol Ther; 1992; 18(3-4):131-4. PubMed ID: 1306801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nanoscale view of supramolecular stereochemistry in self-assembled monolayers of enantiomers and racemates.
    Mamdouh W; Uji-I H; Gesquière A; De Feyter S; Amabilino DB; Abdel-Mottaleb MM; Veciana J; De Schryver FC
    Langmuir; 2004 Oct; 20(22):9628-35. PubMed ID: 15491196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chiral compounds and their pharmacologic effects].
    Slováková A; Hutt AJ
    Ceska Slov Farm; 1999 May; 48(3):107-12. PubMed ID: 10422348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.